Monday 4 August 2025

Pharma & Biotech Start-up & Scale-up News

Featured

LENZ Therapeutics
A late clinical-stage biopharmaceutical company developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia.
Biotechnology
Biocytogen inks antibody deal with BeOne, expanding strategic ties
10 July 2025
article
IDEAYA exercises option for license on Biocytogen’s IDE034
11 November 2024

Latest Ones To Watch News

Biotechnology
Viridian grants Kissei rights to veligrotug and VRDN-003 in Japan
30 July 2025
Biotechnology
LTZ and Lilly link up on myeloid engager therapeutics
30 July 2025
Pharmaceutical
Strong Quviviq sales driving Idorsia toward profitability
30 July 2025
More ones to watch news >
Reset all filters
Refine Search
ARTBIO
ARTBIO
Ascendis Pharma
Ascendis Pharma
Memo Therapeutics
Avidity Biosciences
Apnimed
Neuraxpharm
OncoZenge
Nanobiotix
Summit
MaaT Pharma
Nuvalent
UroGen Pharma
Tubulis
Neurocrine Biosciences
Axsome Therapeutics
Cidara Therapeutics
Halda Therapeutics
Opthea
Soleno Therapeutics
GAIA


Today's issue

Uncertainty about medicines in US-EU trade deal, says VIG
Pharmaceutical
Uncertainty about medicines in US-EU trade deal, says VIG
4 August 2025
Pharmaceutical
IQWiG to investigate routine practice data for new drugs in Germany
4 August 2025
Pharmaceutical
Maziar Mike Doustdar named president and CEO of Novo Nordisk
4 August 2025
Pharmaceutical
Danish pharma body warns EU health data law could stifle innovation
4 August 2025
Pharmaceutical
The week in pharma: action, reaction and insight – week to August 1
3 August 2025
Pharmaceutical
FDA approves novel product for presbyopia
2 August 2025
Biosimilars
Independent Sandoz doing much more than standing on its own two feet
2 August 2025

Company Spotlight

A late clinical-stage biopharmaceutical company developing the first aceclidine-based eye drop to improve vision in patients diagnosed with presbyopia.




Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze